Activity Stream
@moatrx
• 3 weeks ago
Posted a new blog:
US ATOPIC DERMATITIS Competitive Intelligence
US ATOPIC DERMATITIS Competitive Intelligence
Dupilumab holds 70% biologic share in a $5B US market, but FDA black-box warnings push JAK inhibitors into second-line step-edits.
Six agents are approved for...



